# Group MDMA-therapy for Veterans With PTSD

> **NCT05961527** · PHASE1,PHASE2 · COMPLETED · sponsor: **Portland VA Research Foundation, Inc** · enrollment: 23 (actual)

## Conditions studied

- PTSD

## Interventions

- **DRUG:** MDMA
- **BEHAVIORAL:** Group Therapy

## Key facts

- **NCT ID:** NCT05961527
- **Lead sponsor:** Portland VA Research Foundation, Inc
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2025-03-14
- **Final completion:** 2025-03-14
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05961527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05961527, "Group MDMA-therapy for Veterans With PTSD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05961527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*